Form 4: Akebia Therapeutics SVP, Chief Medical Officer Steven Keith Burke Reports Sale of Common Stock to Cover Tax Obligations

Steven Keith Burke, SVP, Chief Medical Officer of Akebia Therapeutics, Inc., sold 7,169 shares of common stock on February 29, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 29, 2024, Steven Keith Burke, the SVP, Chief Medical Officer of Akebia Therapeutics, Inc. (AKBA), sold 7,169 shares of common stock.
• The sale was executed at a price of $1.58 per share.
• The transaction was conducted automatically by the issuer to cover tax withholding obligations associated with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
• Following the transaction, Burke directly owns 695,840 shares of Akebia Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a routine Form 4 filing indicating a stock sale for tax purposes. It doesn't convey strong positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of the executive's long-term outlook on the company.

Stakeholder Impact

• The sale of shares may have a minor dilutive effect on existing shareholders, but the impact is likely minimal given the small number of shares involved.

Key Dates